FDA’s Makary Says Autism Report Isn’t Written, Calls WSJ Story ‘Premature’
Chief Marty Makary says it hasn't even been started yet but that it will be released “within a month,” Bloomberg reported. Meanwhile, Kenvue, the parent company of Tylenol, is seeing its stock drop after The Wall Street Journal's story saying the government plans to link autism with Tylenol use during pregnancy.